Provectus Biopharmaceuticals (PVCT) Long-Term Debt Repayments (2021 - 2025)
Provectus Biopharmaceuticals (PVCT) posted Long-Term Debt Repayments of $86,771 for Q4 2025, up 40.9% from $61,581 a year earlier and up 154.5% from the prior quarter.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Long-Term Debt Repayments (2021 - 2025) Analysis & Trends
For FY2025, Provectus Biopharmaceuticals' Long-Term Debt Repayments came in at $272,994, down 10.5% from FY2024.
- Annual Long-Term Debt Repayments shows a five-year compound annual growth rate of 20.8% (FY2020 to FY2025).
- In prior years, Provectus Biopharmaceuticals' Long-Term Debt Repayments was $305,135 in FY2024 (+7.7%), $283,445 in FY2023 (+9.2%), $259,659 in FY2022 (+4.6%) and $248,177 in FY2021 (+134.2%).
- The Q4 2025 figure stands as the highest quarterly Long-Term Debt Repayments since Q3 2024.
- On a year-over-year basis, Long-Term Debt Repayments increased in four of the last five quarters, with growth averaging 17.0%.
- The strongest year-over-year quarter for Long-Term Debt Repayments in the past five years was Q3 2023, with growth of 525.5%; the weakest was Q3 2022, with a decline of 89.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 86,771.00 |
| Sep 30, 2025 | 34,097.00 |
| Dec 31, 2024 | 61,581.00 |
| Sep 30, 2024 | 243,554.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 48,448.00 |
| Sep 30, 2023 | 82,141.00 |
| Jun 30, 2023 | 68,559.00 |
| Mar 31, 2023 | 84,297.00 |
| Dec 31, 2022 | 93,342.00 |
| Sep 30, 2022 | 13,132.00 |
| Jun 30, 2022 | 69,658.00 |
| Mar 31, 2022 | 83,527.00 |
| Dec 31, 2021 | 29,005.00 |
| Sep 30, 2021 | 123,785.00 |
| Jun 30, 2021 | 20,970.00 |
| Mar 31, 2021 | 74,417.00 |
API Access
Provectus Biopharmaceuticals Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();